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ABSTRACT
Counterfeit drugs (CDs) continue to cause serious public health problems in many countries around the globe, particularly in the African countries 
which are their major consumers. Soft penalties for the drug counterfeiters; recent increase in internet commerce; ignorance and lack of effective 
partnership between drug companies, drug regulatory agencies, law enforcement bodies, customs, among others, have contributed to the rise in 
counterfeiting menace. However, governments at various levels in some of the affected countries do not accede to the menace of CDs, as they are 
implementing many strategies through the recent innovations and advancement in technology to curtail it. Nevertheless, there is still needs for 
taking more rigorous steps in order to achieve complete eradication of the crime. This review article presented the impact of CDs in the Africa’s 
quality health-care delivery, with particular attention to the causes, magnitude, and consequences. The review also identifies areas where concerted 
drug policies and actions are required to eradicate the drug counterfeiting crimes and also provides suggestions to drug’s policymakers and relevant 
stakeholders that may be useful in making decisions that can safeguard the public from the danger of CDs.
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INTRODUCTION
CDs also called as fake drugs, counterfeit medicines or counterfeit 
pharmaceuticals are causing untold suffering to the populace especially 
in some African countries where it takes an alarming proportion from 
the total drugs in circulation. The harmful effect of CDs stretches from 
the people to businesses. It has been reported that up to around 1 million 
innocent people can lose their lives around the globe every year, as 
a result of CDs related cases [1,2], and therefore it is one of the major 
global public health risk [3]. The global CDs trade is a multi-billion dollars 
industry which is steadily flourishing in Africa. In 2008, the United States 
Government estimated the global market value of the counterfeit industry 
to reach USD 500 billion with an increment rate of 1,700% during the 
past decade [4]. The World Health Organization (WHO), estimated global 
sales of counterfeit medications to top USD 75 billion in 2010 alone, 
which is a 90% rise from 5 years before and could be more than 10% of 
all medicines sold worldwide [5]. In the third world countries, i.e., many 
African countries and part of Asia, the percentage in circulation is much 
higher and could be more than 30% [6-9].
The risks for those involve in the dirty business in terms of either 
legal penalties or monetary loss are insignificant, and they generate 
huge profits through trafficking of counterfeit products regardless of 
possibilities for inflicting morbidity and mortality to mankind. The 
penalties labeled for pharmaceutical counterfeiters in most African 
countries did not match the magnitude of their crime. Therefore, the 
profits driven by drug counterfeiting businesses in Africa are high 
enough to keep the business booming, on the other hand, the penalties 
labeled for it are too low to stop the crime from thriving, consequently 
yielding synergy for its rising prevalence. In addition, regulatory 
agencies for drug’s quality, manufacture, importation, and sales in some 
of these countries are very weak [10]. CDs continue to pose significant 
hazards to the public health, waste consumer’s and governments 
income and reduce incentives that might otherwise be used to engage 
in research and development in the affected countries [11].
WHO has provided a working definition of CDs (Box 1), and it can be 
preparations without active ingredients, with an inadequate amount 
of active ingredients, with correct ingredients but do not have the 
legal permit, with the wrong ingredients, with a harmful constituent, 
or preparations that have already expired but relabeled and sold. 
Furthermore, it can also be drug products with active ingredients 
different from what is stated on the package, or with fake packaging [13-
15]. As indicated in Fig. 1, these categories of CDs are in market 
circulation at different percentage levels [16].
The measures being taken to curb the CDs problems in most African 
countries are not significant enough to stop it, as it continues to spread 
like wildfire, hence the urgent need for concerted international efforts 
to stop it. This review article identified various factors that led to 
the recent rising prevalence of CDs in Africa, and it provides updates 
to the drug policymakers and relevant stakeholders on this issues. It 
also highlights various measures which different countries are putting 
in place as well as the areas that need to be given more attention to 
achieve success in the war against CDs crimes.
FACTORS THAT FACILITATE THE PREPONDERANCE OF 
COUNTERFEIT DRUGS IN AFRICA
The factors that led to the prevalence of drugs counterfeiting in Africa 
are depicted in Fig. 2.
With the expansion of internet trading in the recent days, online drug 
retail markets are now generating sales in millions of USD [17]. Internet 
supply chains such as internet pharmacies which are becoming popular 
in recent time seem to be one of the major sources of CDs, and it poses 
an eminent danger to the public especially in more affluent countries 
where a lot of people patronizes it [18]. Unfortunately, consumers are 
mostly unaware of the risks involved in buying lower-priced drugs 
on the internet or purchasing prescription drugs online without a 
prescription, which might end of being a counterfeit product [11,19].
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Lack of adequate training to the staff of drug’s licensing and regulatory 
authorities, corruption, insufficient manpower, and resources are 
among the major barriers that limit African nations from achieving full 
success in fighting CDs crimes [10,20]. The drug markets in the affected 
nations are flooded with fake and substandard drugs, most of which 
originated from overseas, with India and China being considered as 
the major sources [6,21-23]. It has been reported that India probably 
accounts for 12-25% of global supplies of CDs, substandard or 
contaminated medicines [24]. Most of the CDs victims are poor and 
illiterate people who are unaware of the health dangers associated with 
these drugs and patronizes it because of its cheaper price as compare to 
the legitimate authentic ones [6,25].
MAGNITUDE OF THE AFFLICTION
There are limited data on the morbidity and mortality arising from the 
use of counterfeit and substandard pharmaceutical products in Africa, 
due to the lack of resources and/or skills to detect it and the absence or 
weak drug regulatory systems [10]. Therefore, the effects of consuming 
CDs mostly go unnoticed except in such cases where there is occurrence 
of serious injuries or deaths that involve many people [16,26]. However, 
there are some published reports in literature which revealed some 
cases. US giant pharmaceutical firms, Pfizer conducted CDs sanitization 
operations for its products around the globe in 2004 which has led to 
the seizure of counterfeited Pfizer products quantified to be more than 
62 million doses, thereby blocked the passage of these fake medications 
to reach the innocent consumers [27]. An author has analyzed the 
impact of counterfeit antimalarial drugs in Sub-Saharan Africa and 
reported that in each of these countries, about 400,000 children are 
being attacked by malaria disease annually without effective treatment 
because the children received counterfeited or substandard antimalarial 
drugs [28]. Renschler et al. conducted a study on the burden and impact 
of poor-quality, i.e., falsified and substandard antimalarials drugs in 39 
Sub-Saharan African countries [29]. They found that around 122,350 
children under-five deaths were directly linked to the consumption of 
poor-quality antimalarials in these countries in the year 2013 alone. 
Similarly, it has been estimated that about 200,000-450,000 deaths out 
of one million malaria-related deaths in Africa are associated with the 
use of counterfeit antimalarial drugs [6].
Nigeria which is the most populous country in Africa has suffered 
heavily from the menace of drugs counterfeiting and trafficking, 
which has occurred mostly during the era between 1985 and 2000 
that heralded the regime of faking and quackery, to an extent that CDs, 
unlicensed drug vendors, quack doctors and illegal chemist shops 
became very rampant in the country [26]. In 2008, the WHO conducted 
a study to check the quality of antimalarial medicines in circulation 
in 14 African countries and the result revealed that 64 percent of the 
antimalarial drugs that are in circulation in Nigeria (as of that time) 
were either fake or substandard [23].
With around 30,000 illegal pharmacy websites that intruded the 
internet [22], South Africa is struggling with the expansion of online 
marketing of CDs and other illegal products via these malicious internet 
pharmacies. The country seems to become a robust environment for the 
trading of counterfeit pharmaceuticals online in the recent time. This 
rise in prevalence might be as a result of inadequate or failure of the 
relevant authorities to conduct the routine check and properly regulate 
the unregistered and illegal medicines networks in the country [30].
Mwamba et al., 2016, carried out a research to find out marketed 
illegal and legal drugs (albendazole and metronidazole) in the city of 
Lubumbashi in the Democratic Republic of the Congo, a central African 
country. The researchers found that 32% of the drugs samples collected 
do not have legal permit to be marketed and 26% of the samples were 
substandard/counterfeited drugs with active ingredients lower than 
the label claimed. Alarmingly, 78% of their sample size did not fulfill 
US pharmacopeial requirements for albendazole and metronidazole 
tablets and suspensions product, and these malicious products are 
being marketed illegally, which pose a potential risk in the treatment of 
infectious diseases in that locality [31].
GENERAL CONSEQUENCES
The individual consequences of consuming CDs vary from worsening 
of consumer’s health condition or therapeutic failure to the occurrence 
of serious adverse effects or even death. In addition to these health 
hazards, there is also economic detriment which include waste of funds 
by consumers due to purchase of these drugs, loss of revenues by the 
drug companies, loss of taxes by the governments, additional financial 
burden on the governments, and drug firms which are incur as a result 
of fighting the counterfeiters [32].
Someone with advanced technical knowledge but unfortunately with 
a devious mind will misuse his skills by producing tablets or liquid 
preparations with merely just a chalk, flour, sugar solution or even 
harmful substances and deliberately push these malicious products 
into the public markets for his/her personal gains only. The culprits can 
perfectly imitate packaging and labeling of genuine products in such 
a way that when viewed with naked eyes it is almost impossible to 
recognize it as a counterfeit product. They usually make it to resemble 
real patented and branded drug products which had been manufactured 
Box 1: World Health Organization’s definition of counterfeit 
drugs
WHO defined CDs as a medicine, which is deliberately and fraudulently 
mislabeled with respect to identity and/or source. Counterfeiting can 
apply to both branded and generic products [12]
Fig. 1: A pie chart showing different types of counterfeit drugs 
and their estimated percentages in the market circulation for 
most African countries
Fig. 2: Schematic display of various factors that are contributing 
to the rising prevalence of counterfeit drugs in Africa
65
Asian J Pharm Clin Res, Vol 10, Issue 7, 2017, 63-67
 Aminu and Gwarzo 
by a legitimate licensed pharmaceutical company, but it will contain 
nothing than malicious constituents, and sometimes may even contain 
toxic substances.
ECONOMIC CONSEQUENCES
The legitimate pharmaceutical manufacturers are experiencing high 
negative impact of drugs counterfeiting as they are losing about 40% 
of their market to the counterfeiters and their brand names are being 
tarnished [25,28]. The 2009 United Nations report on CDs revealed 
the sales of 45 million doses of counterfeit antimalarial medicines in 
Africa [33]. This result to a significant lost in revenues by the legitimate 
manufacturers of these products which were estimated to be around 
$438 million [33]. CDs sold in Kenya represent up to 30% of total drugs 
sold in the country, equaling approximately $130 million per year [7]. In 
Angola, the head of the National Department of Intellectual Copyright 
Crime of the Economic Police revealed that about 70% of medicines in 
circulation are forgeries [7].
Loss of tax revenues which occurs as a result of CDs is another serious 
affliction bothering African countries. Counterfeit products, including 
CDs, have led to the lost of tax revenues across all the African continent 
which amount to hundreds of millions of dollars. The east African states 
which include Kenya, Burundi, Tanzania, Uganda, and Rwanda reports 
the loss of more than $500 million in unpaid taxes due to the counterfeit 
products circulation. Tanzania in particular reported losing between 
$370 and 617 million annually as a result of tax evasion related to 
counterfeit products [33].
HEALTH RISKS
Counterfeit medicines are associated with many health risks such as 
worsening of their user’s ill condition, precipitating adverse events 
and causing new ailment, hence they are a danger to their consumer’s 
health. CDs are often found to contain harmful, toxic or poisonous 
substances such as paint, antifreeze, brick dust, floor wax [22], heavy 
metals, boric acid, rat poisons, diethylene glycol, and polychlorinated 
biphenyl among others [20,34]. For example, in 2008, there were 
multiple cases of severe injuries and deaths as a result of administering 
adulterated counterfeited heparin to the patients in some countries 
around the world [27]. To cite some examples in Africa, in 1990, 109 
Nigerian children died as a result of administering them adulterated 
paracetamol syrup by their parents [35]. The incidence happened 
because of the manufacturer’s negligence by replacing genuine solvent 
with the counterfeit solvent that contained a deadly level of diethylene 
glycol, which is a known human toxicant and is commonly used in 
industries for non-edible items [35]. Similarly, in November 2008, 34 
children in Nigeria lost their lives and about 50 were hospitalized with 
severe kidney damage after their mothers unknowingly administered a 
CD to them. The counterfeiter imitated original popular babies teething 
mixture brand called “My Pikin” which was intended for soothing 
infant’s teething pains. But unfortunately, the counterfeit mixture 
contained a deadly level of diethylene glycol [36].
Adjei and Ohene published another touching story of Ghanaian old lady 
who developed a serious skin reaction, which was later determined 
to be cancerous, as a result of consuming counterfeited antiepileptic 
drug. An investigation revealed that the drug she consumed was the 
underlined cause of her cancer because it contained carcinogenic 
substance [20].
DRUG RESISTANCE
Counterfeit pharmaceuticals can lead to the treatment failure by 
causing it consumers to develop resistance to the active ingredient, 
thereby making an ultimate disease cure even more difficult to achieve. 
Counterfeit antibiotics with low content of active ingredients are at the 
risk of causing the microbial resistance of that drug to it consumers. 
This is a major concern because the resistant infection can kill, can 
spread to others, and can impose huge costs on individuals, community, 
and government in general [37]. Drug resistance occurring as a result of 
counterfeiting is undermining the global effort to tackle life-threatening 
diseases in Africa such as tuberculosis, HIV-AIDS, and Malaria.
WAY FORWARD
Positive actions taken so far
Governments at various levels, industries, and regulatory authorities in 
the affected countries do not accede to the menace of CDs as they are 
now fighting back by implementing new strategies such as identifying 
rogue shipments and conducting coordinated actions to interrupt its 
supply chains in order to prevent it from reaching the public [22].
In the U.S.A., a member of house of representative, Steve Israel 
proposed a new law to the house that would increase the penalties 
for the sale or trade of counterfeit pharmaceuticals in the U.S.A., 
and the law was unanimously adopted by the House. The act, 
CD Enforcement Act 2014, raises the penalty from a maximum of 
10 years to life in prison, and it also provides an avenue for the 
recall of any drug product that constitutes public health risk [1]. In 
a similar move by Nigerian authorities, the immediate past director 
general of National Agency for Food and Drug Administration 
and Control (NAFDAC), has advocated for the passage of new bill 
which seeks life jail term, confiscation of assets and compensation 
of victims on conviction, in a crimes where CD is found to be the 
proximate cause of injury [13].
Drug counterfeiting is a grievous crime comparable to murder 
hence the use of lenient punishment is inadequate. China, which is 
a country considered to be one of the major sources of counterfeit 
pharmaceuticals, and also a global manufacturer of generic drugs, has 
joined the war against CDs crimes. According to the Chinese media, 
Xinhua News Agency, China is installing “recognition and tracking 
technology” on its drug products, and anti-counterfeit labels are now 
being sealed on each drug package. In addition, the pharmaceutical 
companies in China are also strengthening their cooperation with 
African governments and drug distributors to trace the CDs that are 
being imported in the African countries [9].
Recently, Interpol has coordinated and conducted operations with 
PayPal, MasterCard, Google, Permanent Forum on International 
Pharmaceutical Crime, and Heads of Medicines Agencies and Working 
Group of Enforcement Officers, in 115 countries which targeted the 
sale of CDs by illegal online sources. The operation resulted in the 
complete shutdown of 2414 websites and suspension of 550 online 
advertisements for illicit pharmaceuticals [30]. In addition, a total of 156 
people were arrested, and CDs worth $80 million were confiscated [30]. 
With the support of the WHO, similar exercises were carried out in Africa 
in the recent past. A raid conducted in 2009 by Interpol and the WHO-
supported group, International Medical Products Anti-Counterfeiting 
Taskforce in Uganda has discovered 5 tons of CDs in the Central and 
Eastern Districts of the Country. Furthermore, the health regulatory 
and law enforcement agencies of West African nations in collaboration 
with Interpol and WHO have been running multi-country operations 
aimed to curtail the prevailing transnational CDs criminal networks 
in the region [9]. In 2011, they conducted an operation called “Cobra” 
which led to the seizure of 170 tons of counterfeit pharmaceuticals 
and illicit medical products. In 2012, Angolan custom officials busted 
traffickers trying to import huge quantity of counterfeit antimalarial 
drug (Coartem) in the country [38]. This has occurred when a container 
that was originated from China arrived Luanda filled up with over 
1.4 million packets of the CDs. In 2013, the renowned international 
organization watchdog for trafficking illicit products (World Customs 
Organization) conducted a massive sweep across 16 seaports on the 
east and west coasts of Africa which resulted in the seizure of over 
82 million doses of CDs and other illegal medical products, with an 
estimated value of about $40 million [38]. The CDs found during the raid 
included antibiotics, antiparasitic, antimalarial drugs, contraceptives, 
and cough syrup [38].
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Nigeria has taken the lead in the war against CDs in Africa, as it 
intensified efforts to alleviate drugs criminalities, especially during 
the past one and half decade. The former director general of NAFDAC, 
Professor Dora Akunyili, who is a pharmacist by profession, had 
spent 8 years (2001-2008) trying to cripple the counterfeit networks 
in Nigeria, and she successfully disrupted it [18]. During that period, 
she blacklisted over 30 manufacturers, dismissed several corrupt 
officials, and led many operations against chaotic and illegal drug 
markets [18]. These efforts resulted in the significant reduction on 
CDs trade and circulation in Nigeria between 2001 and 2006 [39,40]. 
Other important steps which NAFDAC has taken include, increasing 
the partnership among relevant agencies such as Nigerian Customs 
Service, Nigerian Immigration Service, Standards Organization 
of Nigeria, and National Drug Law Enforcement Agency. This 
administration of NAFDAC is using latest technologies in fighting the 
crimes, and some other African countries including Sierra Leonean, 
Ghana, Cameroon, and Uganda are learning lessons and intelligence 
from Nigeria on how to effectively combat the fight in their countries 
[23].
Pharmaceutical industries and national drug regulatory authorities 
in some African states are exploring various new cutting edge 
technologies, which include mobile authentication service (MAS), 
handheld spectrometer (TruScan), radio frequency identification 
(RFID), and complex packaging features that are harder to copy. Nigeria 
was the first African nation to integrate mobile telephony - based 
consumer verification into its safety regulations [18], followed by other 
countries such as Ghana and Kenya. The system is now being replicated 
in some Asian countries too [23]. The brilliance of MAS is that it allows 
consumers to protect themselves, by determining the authenticity of the 
product via short message service. This low-tech innovation is helping 
restore the public’s trust in the health sector. RFID is a portable wireless 
device that collects data of tagged materials through radio signals. It 
enables identification of the tagged material with high accuracy [21].
Another recently adopted technology is TruScan, a handheld 
spectrometer being used at airports and border posts to analyze the 
chemical composition of drugs, helping to quickly spot and reveal 
whether the product is genuine or fake in a matter of seconds. Nigeria 
and other African nations have already engaged in using TruScan for 
detection of the quality of medicines. In a similar development, some 
African countries have also started using Black Eye device for drugs 
authentication. Black Eye is another technology developed in Israel and 
works like TruScan [23].
ACTIONS REQUIRED
Stiffer penalties would help sharpen the attitudes of CDs dealers. There 
is an urgent need for the affected countries to implement more rigorous 
legislative measures to treat counterfeiting as a serious crime, and also to 
take decisive measures to minimize corruption. An effective regulatory 
framework would guarantee sufficient supply of legal pharmaceutical 
products as well as provide oversight and timely actions to combat 
counterfeiting. There is also need for the authorities in Africa to do 
more by enhancing collaboration between international bodies, drug 
companies, pharmaceutical trade groups, law enforcement agencies 
and customs officials worldwide, and also to improve partnership with 
legitimate private supply chain, to effectively reduce the prevalence of 
CDs in their countries.
Furthermore, improving education level and enlightenment campaign is 
another important action required, because most of the CDs consumers 
are illiterate and not aware of its possible harmful effects, therefore, 
patronizes the drugs because it is many times cheaper than the genuine 
product and it is easily accessible [41,42]. Therefore, health-care 
professionals can contribute significantly in this direction, by educating 
patients about the dangers of buying or consuming cheaper CDs and 
also enlighten them on how to recognize these drugs, so that they avoid 
them. A recent study showed that pharmacists can help in increasing 
health literacy among the public as well as bring awareness about the 
risk associated with CDs [43].
There is also need for the government to explore ways in order to 
reduce prices of the genuine pharmaceutical products. This could be 
achieved by reducing taxes for the importers and manufacturers, or 
through implementing subsidies on drugs so that the common people 
can get it at affordable prices. Until genuine drugs become accessible 
at cheaper prices, people in the affected countries will continue to 
patronize CDs due to poverty. In addition, it is paramount to ensure 
availability of the genuine drugs in circulation, as the shortage of supply 
encourages the counterfeiters, and also forces the public to seek for 
alternatives which could be CDs. The porous nature of African nation’s 
borders is another contributing factor that further compounded the 
problem. Therefore, authorities need to take strong measures to seal off 
their country’s borders against illicit products, as most of the CDs are 
being smuggled into the countries from overseas. Drug counterfeiting 
crimes are not just a problem worrying African states alone, but a global 
phenomenon that threatens global quality health-care delivery. Hence, 
there is a need for more international collaboration toward designing 
and implementing effective strategies for fighting this inhumane crime.
CONCLUSIONS
CDs are taking silent devastating toll of human beings every year and 
causing serious affliction, especially to the African nations. Drugs 
criminal organizations understand the high margins associated with 
counterfeit products, but among other reasons, lack of stringent laws 
and enforcement of the laws, corruption and minimal possibility of 
being prosecuted, serve as incentives for them to continue causing 
significant public health risks, by exposing millions of people to the 
danger of CDs. Some positive steps have been taken to fight drugs 
counterfeiting by some African governments, their drugs regulatory 
bodies and companies, as well as international organizations such 
as WHO and Interpol through the recent advances in technology 
and globalization. However, to ensure the eradication of drugs 
counterfeiting, the policymakers and relevant stakeholders have to 
consider taking more actions (Box 2).
In addition, health care providers such as pharmacists and clinicians 
are in better position to assist in the war against counterfeit medicines 
by enlightening the consumers with the skills needed to identify CDs 
so that they can be able to reject and report it to the appropriate 
authorities.
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